BioPharma Drug Approval
Envisioned to be "a leading global biopharmaceutical company", Boan Biotech develops biologics for both Chinese and international markets, including E...
April 12, 2023 | News
SLE is a complex autoimmune disease with diverse clinical manifestations involving many organs and systems. It is estimated that China has 1 mill...
April 11, 2023 | News
The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (...
April 11, 2023 | News
The expansion of the Octasa® family in Canada with the launch of Octasa® 1600 mg represents an important step in the strategic partnership of Tillo...
April 07, 2023 | News
Leica Biosystems announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-perfo...
April 04, 2023 | News
In July 2022, the Company entered into a cooperative agreement with China Resource Biopharma ("CRBio") to jointly develop MVR-C5252 in the Greate...
March 30, 2023 | Regulatory
Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of artificial intelligence-based precision small mole...
March 30, 2023 | Regulatory
Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...
March 28, 2023 | News
Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Dr...
March 23, 2023 | News
Aquavit Holdings, the exclusive licensee of Huons Global's Botulinum Toxin in the USA and Canada, will officially unveil the Aquatox™ ...
March 18, 2023 | Regulatory
Glenmark Specialty SA, the subsidiary of Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharmaceuticals company received acceptance from the U...
March 17, 2023 | News
The label expansion means Illuccix is now approved in the U.S. to identify and select patients who are candidates for the only FDA-approved prostate-specif...
March 16, 2023 | News
This is the first-ever global phase III trial for TGCT approved by NMPA and FDA. Pimicotinib (ABSK021)was granted BTD by FDA and CDE, discovered a...
March 16, 2023 | News
The development of new drugs is a lengthy and costly process that can take several years and cost billions of dollars. However, the emergence of artificial...
March 10, 2023 | Opinion
Most Read
Bio Jobs
News
Editor Picks